nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—ABCB1—hematologic cancer	0.175	1	CbGaD
Tolvaptan—ABCB1—Lenalidomide—hematologic cancer	0.035	0.0698	CbGbCtD
Tolvaptan—CYP3A4—Bexarotene—hematologic cancer	0.021	0.0418	CbGbCtD
Tolvaptan—ABCB1—Daunorubicin—hematologic cancer	0.0205	0.0409	CbGbCtD
Tolvaptan—ABCB1—Alitretinoin—hematologic cancer	0.0201	0.0401	CbGbCtD
Tolvaptan—CYP3A4—Lomustine—hematologic cancer	0.0195	0.0389	CbGbCtD
Tolvaptan—CYP3A4—Busulfan—hematologic cancer	0.0195	0.0389	CbGbCtD
Tolvaptan—CYP3A4—Thiotepa—hematologic cancer	0.0174	0.0347	CbGbCtD
Tolvaptan—ABCB1—Imatinib—hematologic cancer	0.0157	0.0314	CbGbCtD
Tolvaptan—ABCB1—Nilotinib—hematologic cancer	0.0143	0.0285	CbGbCtD
Tolvaptan—ABCB1—Vinorelbine—hematologic cancer	0.0142	0.0283	CbGbCtD
Tolvaptan—CYP3A4—Methoxsalen—hematologic cancer	0.0135	0.027	CbGbCtD
Tolvaptan—CYP3A4—Bortezomib—hematologic cancer	0.0129	0.0257	CbGbCtD
Tolvaptan—ABCB1—Dasatinib—hematologic cancer	0.0126	0.0252	CbGbCtD
Tolvaptan—ABCB1—Mitoxantrone—hematologic cancer	0.0125	0.0249	CbGbCtD
Tolvaptan—CYP3A4—Daunorubicin—hematologic cancer	0.0123	0.0245	CbGbCtD
Tolvaptan—ABCB1—Betamethasone—hematologic cancer	0.0111	0.0222	CbGbCtD
Tolvaptan—ABCB1—Gemcitabine—hematologic cancer	0.011	0.022	CbGbCtD
Tolvaptan—ABCB1—Prednisolone—hematologic cancer	0.011	0.0219	CbGbCtD
Tolvaptan—CYP3A4—Cytarabine—hematologic cancer	0.0108	0.0216	CbGbCtD
Tolvaptan—CYP3A4—Teniposide—hematologic cancer	0.0107	0.0213	CbGbCtD
Tolvaptan—ABCB1—Prednisone—hematologic cancer	0.0104	0.0207	CbGbCtD
Tolvaptan—CYP3A4—Ifosfamide—hematologic cancer	0.00986	0.0197	CbGbCtD
Tolvaptan—ABCB1—Irinotecan—hematologic cancer	0.00982	0.0196	CbGbCtD
Tolvaptan—CYP3A4—Imatinib—hematologic cancer	0.00942	0.0188	CbGbCtD
Tolvaptan—CYP3A4—Ruxolitinib—hematologic cancer	0.00887	0.0177	CbGbCtD
Tolvaptan—ABCB1—Vinblastine—hematologic cancer	0.00873	0.0174	CbGbCtD
Tolvaptan—ABCB1—Vincristine—hematologic cancer	0.00858	0.0171	CbGbCtD
Tolvaptan—CYP3A4—Nilotinib—hematologic cancer	0.00856	0.0171	CbGbCtD
Tolvaptan—CYP3A4—Vinorelbine—hematologic cancer	0.00849	0.0169	CbGbCtD
Tolvaptan—ABCB1—Cisplatin—hematologic cancer	0.008	0.016	CbGbCtD
Tolvaptan—ABCB1—Etoposide—hematologic cancer	0.00786	0.0157	CbGbCtD
Tolvaptan—CYP3A4—Triamcinolone—hematologic cancer	0.00776	0.0155	CbGbCtD
Tolvaptan—CYP3A4—Dasatinib—hematologic cancer	0.00756	0.0151	CbGbCtD
Tolvaptan—CYP3A4—Mitoxantrone—hematologic cancer	0.00747	0.0149	CbGbCtD
Tolvaptan—CYP3A4—Betamethasone—hematologic cancer	0.00666	0.0133	CbGbCtD
Tolvaptan—CYP3A4—Prednisolone—hematologic cancer	0.00657	0.0131	CbGbCtD
Tolvaptan—ABCB1—Dexamethasone—hematologic cancer	0.00647	0.0129	CbGbCtD
Tolvaptan—CYP3A4—Prednisone—hematologic cancer	0.00621	0.0124	CbGbCtD
Tolvaptan—CYP3A4—Irinotecan—hematologic cancer	0.00588	0.0117	CbGbCtD
Tolvaptan—ABCB1—Doxorubicin—hematologic cancer	0.00536	0.0107	CbGbCtD
Tolvaptan—CYP3A4—Vinblastine—hematologic cancer	0.00523	0.0104	CbGbCtD
Tolvaptan—ABCB1—Methotrexate—hematologic cancer	0.0052	0.0104	CbGbCtD
Tolvaptan—CYP3A4—Vincristine—hematologic cancer	0.00514	0.0103	CbGbCtD
Tolvaptan—CYP3A4—Etoposide—hematologic cancer	0.00471	0.0094	CbGbCtD
Tolvaptan—CYP3A4—Dexamethasone—hematologic cancer	0.00387	0.00773	CbGbCtD
Tolvaptan—CYP3A4—Doxorubicin—hematologic cancer	0.00321	0.00641	CbGbCtD
Tolvaptan—Zafirlukast—ABCG2—hematologic cancer	0.000877	0.389	CrCbGaD
Tolvaptan—Vismodegib—ABCG2—hematologic cancer	0.000743	0.33	CrCbGaD
Tolvaptan—Vismodegib—ALB—hematologic cancer	0.000324	0.144	CrCbGaD
Tolvaptan—Vismodegib—ABCB1—hematologic cancer	0.000309	0.137	CrCbGaD
Tolvaptan—Ill-defined disorder—Betamethasone—hematologic cancer	6.72e-05	0.000279	CcSEcCtD
Tolvaptan—Headache—Bortezomib—hematologic cancer	6.72e-05	0.000279	CcSEcCtD
Tolvaptan—Discomfort—Triamcinolone—hematologic cancer	6.72e-05	0.000278	CcSEcCtD
Tolvaptan—Hypersensitivity—Ifosfamide—hematologic cancer	6.7e-05	0.000278	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Doxorubicin—hematologic cancer	6.69e-05	0.000277	CcSEcCtD
Tolvaptan—Asthenia—Carmustine—hematologic cancer	6.67e-05	0.000276	CcSEcCtD
Tolvaptan—Body temperature increased—Gemcitabine—hematologic cancer	6.65e-05	0.000276	CcSEcCtD
Tolvaptan—Dry mouth—Triamcinolone—hematologic cancer	6.65e-05	0.000276	CcSEcCtD
Tolvaptan—Renal failure—Methotrexate—hematologic cancer	6.64e-05	0.000275	CcSEcCtD
Tolvaptan—Diarrhoea—Thalidomide—hematologic cancer	6.62e-05	0.000274	CcSEcCtD
Tolvaptan—Dizziness—Thiotepa—hematologic cancer	6.62e-05	0.000274	CcSEcCtD
Tolvaptan—Asthenia—Alitretinoin—hematologic cancer	6.61e-05	0.000274	CcSEcCtD
Tolvaptan—Angiopathy—Prednisone—hematologic cancer	6.58e-05	0.000273	CcSEcCtD
Tolvaptan—Headache—Vinorelbine—hematologic cancer	6.56e-05	0.000272	CcSEcCtD
Tolvaptan—Immune system disorder—Prednisone—hematologic cancer	6.55e-05	0.000271	CcSEcCtD
Tolvaptan—Pollakiuria—Epirubicin—hematologic cancer	6.54e-05	0.000271	CcSEcCtD
Tolvaptan—Hypersensitivity—Vincristine—hematologic cancer	6.54e-05	0.000271	CcSEcCtD
Tolvaptan—Malaise—Dexamethasone—hematologic cancer	6.54e-05	0.000271	CcSEcCtD
Tolvaptan—Malaise—Betamethasone—hematologic cancer	6.54e-05	0.000271	CcSEcCtD
Tolvaptan—Asthenia—Ifosfamide—hematologic cancer	6.53e-05	0.000271	CcSEcCtD
Tolvaptan—Anaphylactic shock—Triamcinolone—hematologic cancer	6.52e-05	0.00027	CcSEcCtD
Tolvaptan—Pruritus—Alitretinoin—hematologic cancer	6.51e-05	0.00027	CcSEcCtD
Tolvaptan—Syncope—Betamethasone—hematologic cancer	6.5e-05	0.000269	CcSEcCtD
Tolvaptan—Syncope—Dexamethasone—hematologic cancer	6.5e-05	0.000269	CcSEcCtD
Tolvaptan—Feeling abnormal—Cisplatin—hematologic cancer	6.47e-05	0.000268	CcSEcCtD
Tolvaptan—Pruritus—Ifosfamide—hematologic cancer	6.44e-05	0.000267	CcSEcCtD
Tolvaptan—Shock—Triamcinolone—hematologic cancer	6.41e-05	0.000266	CcSEcCtD
Tolvaptan—Dizziness—Thalidomide—hematologic cancer	6.4e-05	0.000265	CcSEcCtD
Tolvaptan—Hyperglycaemia—Epirubicin—hematologic cancer	6.39e-05	0.000265	CcSEcCtD
Tolvaptan—Nausea—Bortezomib—hematologic cancer	6.37e-05	0.000264	CcSEcCtD
Tolvaptan—Loss of consciousness—Betamethasone—hematologic cancer	6.37e-05	0.000264	CcSEcCtD
Tolvaptan—Loss of consciousness—Dexamethasone—hematologic cancer	6.37e-05	0.000264	CcSEcCtD
Tolvaptan—Hypersensitivity—Mitoxantrone—hematologic cancer	6.37e-05	0.000264	CcSEcCtD
Tolvaptan—Hypersensitivity—Irinotecan—hematologic cancer	6.37e-05	0.000264	CcSEcCtD
Tolvaptan—Asthenia—Vincristine—hematologic cancer	6.37e-05	0.000264	CcSEcCtD
Tolvaptan—Diarrhoea—Carmustine—hematologic cancer	6.36e-05	0.000263	CcSEcCtD
Tolvaptan—Nausea—Bleomycin—hematologic cancer	6.32e-05	0.000262	CcSEcCtD
Tolvaptan—Malnutrition—Prednisone—hematologic cancer	6.31e-05	0.000262	CcSEcCtD
Tolvaptan—Diarrhoea—Alitretinoin—hematologic cancer	6.3e-05	0.000261	CcSEcCtD
Tolvaptan—Headache—Thiotepa—hematologic cancer	6.27e-05	0.00026	CcSEcCtD
Tolvaptan—Decreased appetite—Etoposide—hematologic cancer	6.25e-05	0.000259	CcSEcCtD
Tolvaptan—Diarrhoea—Ifosfamide—hematologic cancer	6.23e-05	0.000258	CcSEcCtD
Tolvaptan—Nausea—Vinorelbine—hematologic cancer	6.22e-05	0.000258	CcSEcCtD
Tolvaptan—Renal failure—Epirubicin—hematologic cancer	6.21e-05	0.000257	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Etoposide—hematologic cancer	6.21e-05	0.000257	CcSEcCtD
Tolvaptan—Body temperature increased—Cisplatin—hematologic cancer	6.2e-05	0.000257	CcSEcCtD
Tolvaptan—Asthenia—Irinotecan—hematologic cancer	6.2e-05	0.000257	CcSEcCtD
Tolvaptan—Asthenia—Mitoxantrone—hematologic cancer	6.2e-05	0.000257	CcSEcCtD
Tolvaptan—Dizziness—Carmustine—hematologic cancer	6.15e-05	0.000255	CcSEcCtD
Tolvaptan—Constipation—Etoposide—hematologic cancer	6.15e-05	0.000255	CcSEcCtD
Tolvaptan—Discomfort—Betamethasone—hematologic cancer	6.1e-05	0.000253	CcSEcCtD
Tolvaptan—Discomfort—Dexamethasone—hematologic cancer	6.1e-05	0.000253	CcSEcCtD
Tolvaptan—Dizziness—Alitretinoin—hematologic cancer	6.09e-05	0.000252	CcSEcCtD
Tolvaptan—Diarrhoea—Vincristine—hematologic cancer	6.07e-05	0.000252	CcSEcCtD
Tolvaptan—Headache—Thalidomide—hematologic cancer	6.06e-05	0.000251	CcSEcCtD
Tolvaptan—Pollakiuria—Doxorubicin—hematologic cancer	6.06e-05	0.000251	CcSEcCtD
Tolvaptan—Asthenia—Gemcitabine—hematologic cancer	6.04e-05	0.00025	CcSEcCtD
Tolvaptan—Dizziness—Ifosfamide—hematologic cancer	6.02e-05	0.000249	CcSEcCtD
Tolvaptan—Urinary tract disorder—Methotrexate—hematologic cancer	5.98e-05	0.000248	CcSEcCtD
Tolvaptan—Pruritus—Gemcitabine—hematologic cancer	5.96e-05	0.000247	CcSEcCtD
Tolvaptan—Nausea—Thiotepa—hematologic cancer	5.94e-05	0.000246	CcSEcCtD
Tolvaptan—Urethral disorder—Methotrexate—hematologic cancer	5.94e-05	0.000246	CcSEcCtD
Tolvaptan—Feeling abnormal—Etoposide—hematologic cancer	5.92e-05	0.000245	CcSEcCtD
Tolvaptan—Anaphylactic shock—Dexamethasone—hematologic cancer	5.92e-05	0.000245	CcSEcCtD
Tolvaptan—Anaphylactic shock—Betamethasone—hematologic cancer	5.92e-05	0.000245	CcSEcCtD
Tolvaptan—Hyperglycaemia—Doxorubicin—hematologic cancer	5.91e-05	0.000245	CcSEcCtD
Tolvaptan—Diarrhoea—Irinotecan—hematologic cancer	5.91e-05	0.000245	CcSEcCtD
Tolvaptan—Diarrhoea—Mitoxantrone—hematologic cancer	5.91e-05	0.000245	CcSEcCtD
Tolvaptan—Dizziness—Vincristine—hematologic cancer	5.87e-05	0.000243	CcSEcCtD
Tolvaptan—Ill-defined disorder—Prednisone—hematologic cancer	5.86e-05	0.000243	CcSEcCtD
Tolvaptan—Feeling abnormal—Prednisolone—hematologic cancer	5.84e-05	0.000242	CcSEcCtD
Tolvaptan—Headache—Carmustine—hematologic cancer	5.82e-05	0.000241	CcSEcCtD
Tolvaptan—Shock—Dexamethasone—hematologic cancer	5.82e-05	0.000241	CcSEcCtD
Tolvaptan—Shock—Betamethasone—hematologic cancer	5.82e-05	0.000241	CcSEcCtD
Tolvaptan—Nervous system disorder—Betamethasone—hematologic cancer	5.8e-05	0.00024	CcSEcCtD
Tolvaptan—Nervous system disorder—Dexamethasone—hematologic cancer	5.8e-05	0.00024	CcSEcCtD
Tolvaptan—Hypersensitivity—Cisplatin—hematologic cancer	5.78e-05	0.000239	CcSEcCtD
Tolvaptan—Headache—Alitretinoin—hematologic cancer	5.77e-05	0.000239	CcSEcCtD
Tolvaptan—Diarrhoea—Gemcitabine—hematologic cancer	5.76e-05	0.000239	CcSEcCtD
Tolvaptan—Nausea—Thalidomide—hematologic cancer	5.75e-05	0.000238	CcSEcCtD
Tolvaptan—Renal failure—Doxorubicin—hematologic cancer	5.75e-05	0.000238	CcSEcCtD
Tolvaptan—Dizziness—Irinotecan—hematologic cancer	5.71e-05	0.000237	CcSEcCtD
Tolvaptan—Malaise—Prednisone—hematologic cancer	5.69e-05	0.000236	CcSEcCtD
Tolvaptan—Body temperature increased—Etoposide—hematologic cancer	5.68e-05	0.000235	CcSEcCtD
Tolvaptan—Syncope—Prednisone—hematologic cancer	5.66e-05	0.000235	CcSEcCtD
Tolvaptan—Anorexia—Betamethasone—hematologic cancer	5.64e-05	0.000234	CcSEcCtD
Tolvaptan—Anorexia—Dexamethasone—hematologic cancer	5.64e-05	0.000234	CcSEcCtD
Tolvaptan—Asthenia—Cisplatin—hematologic cancer	5.63e-05	0.000233	CcSEcCtD
Tolvaptan—Cardiac disorder—Methotrexate—hematologic cancer	5.62e-05	0.000233	CcSEcCtD
Tolvaptan—Urinary tract disorder—Epirubicin—hematologic cancer	5.6e-05	0.000232	CcSEcCtD
Tolvaptan—Connective tissue disorder—Epirubicin—hematologic cancer	5.57e-05	0.000231	CcSEcCtD
Tolvaptan—Urethral disorder—Epirubicin—hematologic cancer	5.56e-05	0.00023	CcSEcCtD
Tolvaptan—Headache—Vincristine—hematologic cancer	5.56e-05	0.00023	CcSEcCtD
Tolvaptan—Loss of consciousness—Prednisone—hematologic cancer	5.55e-05	0.00023	CcSEcCtD
Tolvaptan—Nausea—Carmustine—hematologic cancer	5.52e-05	0.000229	CcSEcCtD
Tolvaptan—Angiopathy—Methotrexate—hematologic cancer	5.5e-05	0.000228	CcSEcCtD
Tolvaptan—Immune system disorder—Methotrexate—hematologic cancer	5.47e-05	0.000227	CcSEcCtD
Tolvaptan—Nausea—Alitretinoin—hematologic cancer	5.47e-05	0.000227	CcSEcCtD
Tolvaptan—Mediastinal disorder—Methotrexate—hematologic cancer	5.46e-05	0.000226	CcSEcCtD
Tolvaptan—Headache—Mitoxantrone—hematologic cancer	5.41e-05	0.000224	CcSEcCtD
Tolvaptan—Headache—Irinotecan—hematologic cancer	5.41e-05	0.000224	CcSEcCtD
Tolvaptan—Nausea—Ifosfamide—hematologic cancer	5.41e-05	0.000224	CcSEcCtD
Tolvaptan—Feeling abnormal—Triamcinolone—hematologic cancer	5.37e-05	0.000223	CcSEcCtD
Tolvaptan—Diarrhoea—Cisplatin—hematologic cancer	5.37e-05	0.000222	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	5.34e-05	0.000221	CcSEcCtD
Tolvaptan—Discomfort—Prednisone—hematologic cancer	5.31e-05	0.00022	CcSEcCtD
Tolvaptan—Hypersensitivity—Etoposide—hematologic cancer	5.3e-05	0.000219	CcSEcCtD
Tolvaptan—Malnutrition—Methotrexate—hematologic cancer	5.28e-05	0.000219	CcSEcCtD
Tolvaptan—Headache—Gemcitabine—hematologic cancer	5.27e-05	0.000218	CcSEcCtD
Tolvaptan—Nausea—Vincristine—hematologic cancer	5.27e-05	0.000218	CcSEcCtD
Tolvaptan—Cardiac disorder—Epirubicin—hematologic cancer	5.26e-05	0.000218	CcSEcCtD
Tolvaptan—Hypersensitivity—Prednisolone—hematologic cancer	5.22e-05	0.000216	CcSEcCtD
Tolvaptan—Urinary tract disorder—Doxorubicin—hematologic cancer	5.18e-05	0.000215	CcSEcCtD
Tolvaptan—Dysgeusia—Methotrexate—hematologic cancer	5.17e-05	0.000214	CcSEcCtD
Tolvaptan—Asthenia—Etoposide—hematologic cancer	5.16e-05	0.000214	CcSEcCtD
Tolvaptan—Connective tissue disorder—Doxorubicin—hematologic cancer	5.16e-05	0.000214	CcSEcCtD
Tolvaptan—Body temperature increased—Triamcinolone—hematologic cancer	5.15e-05	0.000214	CcSEcCtD
Tolvaptan—Anaphylactic shock—Prednisone—hematologic cancer	5.15e-05	0.000213	CcSEcCtD
Tolvaptan—Angiopathy—Epirubicin—hematologic cancer	5.15e-05	0.000213	CcSEcCtD
Tolvaptan—Urethral disorder—Doxorubicin—hematologic cancer	5.14e-05	0.000213	CcSEcCtD
Tolvaptan—Decreased appetite—Dexamethasone—hematologic cancer	5.14e-05	0.000213	CcSEcCtD
Tolvaptan—Decreased appetite—Betamethasone—hematologic cancer	5.14e-05	0.000213	CcSEcCtD
Tolvaptan—Nausea—Irinotecan—hematologic cancer	5.13e-05	0.000213	CcSEcCtD
Tolvaptan—Nausea—Mitoxantrone—hematologic cancer	5.13e-05	0.000213	CcSEcCtD
Tolvaptan—Immune system disorder—Epirubicin—hematologic cancer	5.12e-05	0.000212	CcSEcCtD
Tolvaptan—Mediastinal disorder—Epirubicin—hematologic cancer	5.11e-05	0.000212	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Betamethasone—hematologic cancer	5.11e-05	0.000212	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Dexamethasone—hematologic cancer	5.11e-05	0.000212	CcSEcCtD
Tolvaptan—Pruritus—Etoposide—hematologic cancer	5.09e-05	0.000211	CcSEcCtD
Tolvaptan—Shock—Prednisone—hematologic cancer	5.07e-05	0.00021	CcSEcCtD
Tolvaptan—Nervous system disorder—Prednisone—hematologic cancer	5.05e-05	0.000209	CcSEcCtD
Tolvaptan—Skin disorder—Prednisone—hematologic cancer	5e-05	0.000207	CcSEcCtD
Tolvaptan—Nausea—Gemcitabine—hematologic cancer	5e-05	0.000207	CcSEcCtD
Tolvaptan—Malnutrition—Epirubicin—hematologic cancer	4.94e-05	0.000205	CcSEcCtD
Tolvaptan—Diarrhoea—Etoposide—hematologic cancer	4.92e-05	0.000204	CcSEcCtD
Tolvaptan—Anorexia—Prednisone—hematologic cancer	4.91e-05	0.000203	CcSEcCtD
Tolvaptan—Ill-defined disorder—Methotrexate—hematologic cancer	4.89e-05	0.000203	CcSEcCtD
Tolvaptan—Feeling abnormal—Betamethasone—hematologic cancer	4.87e-05	0.000202	CcSEcCtD
Tolvaptan—Feeling abnormal—Dexamethasone—hematologic cancer	4.87e-05	0.000202	CcSEcCtD
Tolvaptan—Cardiac disorder—Doxorubicin—hematologic cancer	4.87e-05	0.000202	CcSEcCtD
Tolvaptan—Dysgeusia—Epirubicin—hematologic cancer	4.83e-05	0.0002	CcSEcCtD
Tolvaptan—Hypersensitivity—Triamcinolone—hematologic cancer	4.8e-05	0.000199	CcSEcCtD
Tolvaptan—Angiopathy—Doxorubicin—hematologic cancer	4.76e-05	0.000197	CcSEcCtD
Tolvaptan—Malaise—Methotrexate—hematologic cancer	4.76e-05	0.000197	CcSEcCtD
Tolvaptan—Dizziness—Etoposide—hematologic cancer	4.75e-05	0.000197	CcSEcCtD
Tolvaptan—Immune system disorder—Doxorubicin—hematologic cancer	4.74e-05	0.000196	CcSEcCtD
Tolvaptan—Mediastinal disorder—Doxorubicin—hematologic cancer	4.73e-05	0.000196	CcSEcCtD
Tolvaptan—Dizziness—Prednisolone—hematologic cancer	4.69e-05	0.000194	CcSEcCtD
Tolvaptan—Asthenia—Triamcinolone—hematologic cancer	4.68e-05	0.000194	CcSEcCtD
Tolvaptan—Body temperature increased—Betamethasone—hematologic cancer	4.68e-05	0.000194	CcSEcCtD
Tolvaptan—Body temperature increased—Dexamethasone—hematologic cancer	4.68e-05	0.000194	CcSEcCtD
Tolvaptan—Nausea—Cisplatin—hematologic cancer	4.66e-05	0.000193	CcSEcCtD
Tolvaptan—Pruritus—Triamcinolone—hematologic cancer	4.61e-05	0.000191	CcSEcCtD
Tolvaptan—Ill-defined disorder—Epirubicin—hematologic cancer	4.58e-05	0.00019	CcSEcCtD
Tolvaptan—Malnutrition—Doxorubicin—hematologic cancer	4.57e-05	0.000189	CcSEcCtD
Tolvaptan—Headache—Etoposide—hematologic cancer	4.5e-05	0.000187	CcSEcCtD
Tolvaptan—Decreased appetite—Prednisone—hematologic cancer	4.48e-05	0.000186	CcSEcCtD
Tolvaptan—Dysgeusia—Doxorubicin—hematologic cancer	4.47e-05	0.000185	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.46e-05	0.000185	CcSEcCtD
Tolvaptan—Malaise—Epirubicin—hematologic cancer	4.45e-05	0.000184	CcSEcCtD
Tolvaptan—Headache—Prednisolone—hematologic cancer	4.44e-05	0.000184	CcSEcCtD
Tolvaptan—Discomfort—Methotrexate—hematologic cancer	4.44e-05	0.000184	CcSEcCtD
Tolvaptan—Syncope—Epirubicin—hematologic cancer	4.43e-05	0.000183	CcSEcCtD
Tolvaptan—Constipation—Prednisone—hematologic cancer	4.41e-05	0.000183	CcSEcCtD
Tolvaptan—Loss of consciousness—Epirubicin—hematologic cancer	4.34e-05	0.00018	CcSEcCtD
Tolvaptan—Dizziness—Triamcinolone—hematologic cancer	4.31e-05	0.000179	CcSEcCtD
Tolvaptan—Anaphylactic shock—Methotrexate—hematologic cancer	4.31e-05	0.000178	CcSEcCtD
Tolvaptan—Nausea—Etoposide—hematologic cancer	4.27e-05	0.000177	CcSEcCtD
Tolvaptan—Feeling abnormal—Prednisone—hematologic cancer	4.25e-05	0.000176	CcSEcCtD
Tolvaptan—Asthenia—Betamethasone—hematologic cancer	4.24e-05	0.000176	CcSEcCtD
Tolvaptan—Asthenia—Dexamethasone—hematologic cancer	4.24e-05	0.000176	CcSEcCtD
Tolvaptan—Ill-defined disorder—Doxorubicin—hematologic cancer	4.24e-05	0.000176	CcSEcCtD
Tolvaptan—Nervous system disorder—Methotrexate—hematologic cancer	4.22e-05	0.000175	CcSEcCtD
Tolvaptan—Nausea—Prednisolone—hematologic cancer	4.21e-05	0.000174	CcSEcCtD
Tolvaptan—Pruritus—Dexamethasone—hematologic cancer	4.18e-05	0.000173	CcSEcCtD
Tolvaptan—Pruritus—Betamethasone—hematologic cancer	4.18e-05	0.000173	CcSEcCtD
Tolvaptan—Skin disorder—Methotrexate—hematologic cancer	4.18e-05	0.000173	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.17e-05	0.000173	CcSEcCtD
Tolvaptan—Discomfort—Epirubicin—hematologic cancer	4.15e-05	0.000172	CcSEcCtD
Tolvaptan—Malaise—Doxorubicin—hematologic cancer	4.12e-05	0.000171	CcSEcCtD
Tolvaptan—Dry mouth—Epirubicin—hematologic cancer	4.11e-05	0.00017	CcSEcCtD
Tolvaptan—Anorexia—Methotrexate—hematologic cancer	4.1e-05	0.00017	CcSEcCtD
Tolvaptan—Syncope—Doxorubicin—hematologic cancer	4.1e-05	0.00017	CcSEcCtD
Tolvaptan—Headache—Triamcinolone—hematologic cancer	4.08e-05	0.000169	CcSEcCtD
Tolvaptan—Body temperature increased—Prednisone—hematologic cancer	4.07e-05	0.000169	CcSEcCtD
Tolvaptan—Diarrhoea—Betamethasone—hematologic cancer	4.05e-05	0.000168	CcSEcCtD
Tolvaptan—Diarrhoea—Dexamethasone—hematologic cancer	4.05e-05	0.000168	CcSEcCtD
Tolvaptan—Anaphylactic shock—Epirubicin—hematologic cancer	4.03e-05	0.000167	CcSEcCtD
Tolvaptan—Loss of consciousness—Doxorubicin—hematologic cancer	4.01e-05	0.000166	CcSEcCtD
Tolvaptan—Shock—Epirubicin—hematologic cancer	3.96e-05	0.000164	CcSEcCtD
Tolvaptan—Nervous system disorder—Epirubicin—hematologic cancer	3.95e-05	0.000164	CcSEcCtD
Tolvaptan—Skin disorder—Epirubicin—hematologic cancer	3.91e-05	0.000162	CcSEcCtD
Tolvaptan—Dizziness—Dexamethasone—hematologic cancer	3.91e-05	0.000162	CcSEcCtD
Tolvaptan—Dizziness—Betamethasone—hematologic cancer	3.91e-05	0.000162	CcSEcCtD
Tolvaptan—Nausea—Triamcinolone—hematologic cancer	3.87e-05	0.00016	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	3.86e-05	0.00016	CcSEcCtD
Tolvaptan—Discomfort—Doxorubicin—hematologic cancer	3.84e-05	0.000159	CcSEcCtD
Tolvaptan—Anorexia—Epirubicin—hematologic cancer	3.84e-05	0.000159	CcSEcCtD
Tolvaptan—Dry mouth—Doxorubicin—hematologic cancer	3.8e-05	0.000158	CcSEcCtD
Tolvaptan—Hypersensitivity—Prednisone—hematologic cancer	3.8e-05	0.000157	CcSEcCtD
Tolvaptan—Decreased appetite—Methotrexate—hematologic cancer	3.74e-05	0.000155	CcSEcCtD
Tolvaptan—Anaphylactic shock—Doxorubicin—hematologic cancer	3.73e-05	0.000154	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.72e-05	0.000154	CcSEcCtD
Tolvaptan—Headache—Dexamethasone—hematologic cancer	3.71e-05	0.000154	CcSEcCtD
Tolvaptan—Headache—Betamethasone—hematologic cancer	3.71e-05	0.000154	CcSEcCtD
Tolvaptan—Asthenia—Prednisone—hematologic cancer	3.7e-05	0.000153	CcSEcCtD
Tolvaptan—Shock—Doxorubicin—hematologic cancer	3.67e-05	0.000152	CcSEcCtD
Tolvaptan—Nervous system disorder—Doxorubicin—hematologic cancer	3.66e-05	0.000151	CcSEcCtD
Tolvaptan—Pruritus—Prednisone—hematologic cancer	3.64e-05	0.000151	CcSEcCtD
Tolvaptan—Skin disorder—Doxorubicin—hematologic cancer	3.62e-05	0.00015	CcSEcCtD
Tolvaptan—Anorexia—Doxorubicin—hematologic cancer	3.55e-05	0.000147	CcSEcCtD
Tolvaptan—Feeling abnormal—Methotrexate—hematologic cancer	3.55e-05	0.000147	CcSEcCtD
Tolvaptan—Diarrhoea—Prednisone—hematologic cancer	3.52e-05	0.000146	CcSEcCtD
Tolvaptan—Nausea—Betamethasone—hematologic cancer	3.51e-05	0.000146	CcSEcCtD
Tolvaptan—Nausea—Dexamethasone—hematologic cancer	3.51e-05	0.000146	CcSEcCtD
Tolvaptan—Decreased appetite—Epirubicin—hematologic cancer	3.5e-05	0.000145	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.48e-05	0.000144	CcSEcCtD
Tolvaptan—Constipation—Epirubicin—hematologic cancer	3.45e-05	0.000143	CcSEcCtD
Tolvaptan—Dizziness—Prednisone—hematologic cancer	3.41e-05	0.000141	CcSEcCtD
Tolvaptan—Body temperature increased—Methotrexate—hematologic cancer	3.4e-05	0.000141	CcSEcCtD
Tolvaptan—Feeling abnormal—Epirubicin—hematologic cancer	3.32e-05	0.000138	CcSEcCtD
Tolvaptan—Decreased appetite—Doxorubicin—hematologic cancer	3.24e-05	0.000134	CcSEcCtD
Tolvaptan—Headache—Prednisone—hematologic cancer	3.23e-05	0.000134	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.22e-05	0.000133	CcSEcCtD
Tolvaptan—Constipation—Doxorubicin—hematologic cancer	3.19e-05	0.000132	CcSEcCtD
Tolvaptan—Body temperature increased—Epirubicin—hematologic cancer	3.18e-05	0.000132	CcSEcCtD
Tolvaptan—Hypersensitivity—Methotrexate—hematologic cancer	3.17e-05	0.000131	CcSEcCtD
Tolvaptan—Asthenia—Methotrexate—hematologic cancer	3.09e-05	0.000128	CcSEcCtD
Tolvaptan—Feeling abnormal—Doxorubicin—hematologic cancer	3.07e-05	0.000127	CcSEcCtD
Tolvaptan—Nausea—Prednisone—hematologic cancer	3.06e-05	0.000127	CcSEcCtD
Tolvaptan—Pruritus—Methotrexate—hematologic cancer	3.05e-05	0.000126	CcSEcCtD
Tolvaptan—Hypersensitivity—Epirubicin—hematologic cancer	2.97e-05	0.000123	CcSEcCtD
Tolvaptan—Body temperature increased—Doxorubicin—hematologic cancer	2.95e-05	0.000122	CcSEcCtD
Tolvaptan—Diarrhoea—Methotrexate—hematologic cancer	2.95e-05	0.000122	CcSEcCtD
Tolvaptan—Asthenia—Epirubicin—hematologic cancer	2.89e-05	0.00012	CcSEcCtD
Tolvaptan—Pruritus—Epirubicin—hematologic cancer	2.85e-05	0.000118	CcSEcCtD
Tolvaptan—Dizziness—Methotrexate—hematologic cancer	2.85e-05	0.000118	CcSEcCtD
Tolvaptan—Diarrhoea—Epirubicin—hematologic cancer	2.76e-05	0.000114	CcSEcCtD
Tolvaptan—Hypersensitivity—Doxorubicin—hematologic cancer	2.75e-05	0.000114	CcSEcCtD
Tolvaptan—Headache—Methotrexate—hematologic cancer	2.7e-05	0.000112	CcSEcCtD
Tolvaptan—Asthenia—Doxorubicin—hematologic cancer	2.67e-05	0.000111	CcSEcCtD
Tolvaptan—Dizziness—Epirubicin—hematologic cancer	2.66e-05	0.00011	CcSEcCtD
Tolvaptan—Pruritus—Doxorubicin—hematologic cancer	2.64e-05	0.000109	CcSEcCtD
Tolvaptan—Nausea—Methotrexate—hematologic cancer	2.56e-05	0.000106	CcSEcCtD
Tolvaptan—Diarrhoea—Doxorubicin—hematologic cancer	2.55e-05	0.000106	CcSEcCtD
Tolvaptan—Headache—Epirubicin—hematologic cancer	2.52e-05	0.000105	CcSEcCtD
Tolvaptan—Dizziness—Doxorubicin—hematologic cancer	2.47e-05	0.000102	CcSEcCtD
Tolvaptan—Nausea—Epirubicin—hematologic cancer	2.39e-05	9.91e-05	CcSEcCtD
Tolvaptan—Headache—Doxorubicin—hematologic cancer	2.34e-05	9.68e-05	CcSEcCtD
Tolvaptan—Nausea—Doxorubicin—hematologic cancer	2.21e-05	9.17e-05	CcSEcCtD
Tolvaptan—AVPR2—Signaling Pathways—TSC2—hematologic cancer	2.17e-05	0.00027	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	2.13e-05	0.000265	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	2.12e-05	0.000264	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—NUP214—hematologic cancer	2.11e-05	0.000263	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FGFR3—hematologic cancer	2.1e-05	0.000262	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—AKT1—hematologic cancer	2.1e-05	0.000261	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	2.09e-05	0.00026	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FGFR3—hematologic cancer	2.09e-05	0.00026	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAPK14—hematologic cancer	2.08e-05	0.000259	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	2.08e-05	0.000259	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	2.07e-05	0.000258	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAPK14—hematologic cancer	2.07e-05	0.000257	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ESR1—hematologic cancer	2.04e-05	0.000254	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ESR1—hematologic cancer	2.03e-05	0.000252	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FN1—hematologic cancer	2.02e-05	0.000251	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FN1—hematologic cancer	2e-05	0.000249	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NFKBIA—hematologic cancer	1.99e-05	0.000248	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—BAD—hematologic cancer	1.99e-05	0.000248	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CDA—hematologic cancer	1.99e-05	0.000247	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NFKBIA—hematologic cancer	1.98e-05	0.000246	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—BAD—hematologic cancer	1.98e-05	0.000246	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	1.98e-05	0.000246	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NOTCH1—hematologic cancer	1.97e-05	0.000246	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOTCH1—hematologic cancer	1.96e-05	0.000244	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CD80—hematologic cancer	1.93e-05	0.000241	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CG—hematologic cancer	1.93e-05	0.00024	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—KIT—hematologic cancer	1.93e-05	0.00024	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—NRAS—hematologic cancer	1.93e-05	0.00024	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CD80—hematologic cancer	1.92e-05	0.000239	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—KIT—hematologic cancer	1.92e-05	0.000239	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CG—hematologic cancer	1.92e-05	0.000239	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—NRAS—hematologic cancer	1.92e-05	0.000239	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PC—hematologic cancer	1.91e-05	0.000238	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PTPN11—hematologic cancer	1.9e-05	0.000236	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PTPN11—hematologic cancer	1.88e-05	0.000234	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	1.88e-05	0.000234	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	1.85e-05	0.00023	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—MAPK3—hematologic cancer	1.85e-05	0.00023	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GBA—hematologic cancer	1.85e-05	0.00023	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC35B2—hematologic cancer	1.85e-05	0.00023	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.85e-05	0.00023	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CREB1—hematologic cancer	1.84e-05	0.000229	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—MAPK3—hematologic cancer	1.84e-05	0.000229	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CREB1—hematologic cancer	1.82e-05	0.000227	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—BRAF—hematologic cancer	1.81e-05	0.000226	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—BRAF—hematologic cancer	1.8e-05	0.000224	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCL2—hematologic cancer	1.8e-05	0.000224	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6R—hematologic cancer	1.79e-05	0.000223	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CREBBP—hematologic cancer	1.79e-05	0.000223	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCL2—hematologic cancer	1.78e-05	0.000222	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6R—hematologic cancer	1.78e-05	0.000222	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CREBBP—hematologic cancer	1.78e-05	0.000221	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PHYH—hematologic cancer	1.77e-05	0.00022	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GMPS—hematologic cancer	1.77e-05	0.00022	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—FTCD—hematologic cancer	1.77e-05	0.00022	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAP2K1—hematologic cancer	1.71e-05	0.000213	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CD—hematologic cancer	1.7e-05	0.000211	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAP2K1—hematologic cancer	1.7e-05	0.000211	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MTAP—hematologic cancer	1.69e-05	0.00021	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	1.69e-05	0.00021	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CD—hematologic cancer	1.68e-05	0.00021	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PIK3CA—hematologic cancer	1.68e-05	0.000209	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PIK3CA—hematologic cancer	1.67e-05	0.000208	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—KRAS—hematologic cancer	1.66e-05	0.000207	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	1.65e-05	0.000206	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—KRAS—hematologic cancer	1.65e-05	0.000205	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FGF2—hematologic cancer	1.62e-05	0.000202	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.62e-05	0.000201	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FGF2—hematologic cancer	1.61e-05	0.000201	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	1.61e-05	0.000201	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	1.61e-05	0.0002	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3R1—hematologic cancer	1.6e-05	0.0002	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3R1—hematologic cancer	1.59e-05	0.000198	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	1.56e-05	0.000194	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—JAK2—hematologic cancer	1.56e-05	0.000194	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	1.55e-05	0.000194	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.55e-05	0.000193	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—JAK2—hematologic cancer	1.55e-05	0.000193	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PIK3CA—hematologic cancer	1.53e-05	0.00019	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	1.52e-05	0.000189	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MDM2—hematologic cancer	1.52e-05	0.000189	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PIK3CA—hematologic cancer	1.52e-05	0.000189	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MDM2—hematologic cancer	1.51e-05	0.000188	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—FHL2—hematologic cancer	1.51e-05	0.000188	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	1.48e-05	0.000185	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MTOR—hematologic cancer	1.48e-05	0.000184	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CB—hematologic cancer	1.48e-05	0.000184	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AGRN—hematologic cancer	1.48e-05	0.000184	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CB—hematologic cancer	1.47e-05	0.000183	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MTOR—hematologic cancer	1.47e-05	0.000183	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	1.44e-05	0.000179	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HRAS—hematologic cancer	1.41e-05	0.000176	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.41e-05	0.000176	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ASNS—hematologic cancer	1.41e-05	0.000176	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—DCK—hematologic cancer	1.41e-05	0.000176	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	1.4e-05	0.000175	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HRAS—hematologic cancer	1.4e-05	0.000175	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—IDH2—hematologic cancer	1.4e-05	0.000174	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HMMR—hematologic cancer	1.4e-05	0.000174	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CDKN1B—hematologic cancer	1.39e-05	0.000173	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CDKN1B—hematologic cancer	1.38e-05	0.000172	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—AKT1—hematologic cancer	1.37e-05	0.000171	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—AKT1—hematologic cancer	1.36e-05	0.00017	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CASP3—hematologic cancer	1.36e-05	0.000169	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL2—hematologic cancer	1.36e-05	0.000169	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6—hematologic cancer	1.35e-05	0.000168	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CASP3—hematologic cancer	1.35e-05	0.000168	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL2—hematologic cancer	1.35e-05	0.000168	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6—hematologic cancer	1.34e-05	0.000167	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HDC—hematologic cancer	1.34e-05	0.000167	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	1.33e-05	0.000165	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCND1—hematologic cancer	1.32e-05	0.000165	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—JUN—hematologic cancer	1.32e-05	0.000165	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ARNTL—hematologic cancer	1.32e-05	0.000164	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCND1—hematologic cancer	1.31e-05	0.000164	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—JUN—hematologic cancer	1.31e-05	0.000163	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	1.29e-05	0.000161	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	1.29e-05	0.00016	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CDKN1A—hematologic cancer	1.28e-05	0.000159	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CA9—hematologic cancer	1.28e-05	0.000159	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ACP5—hematologic cancer	1.28e-05	0.000159	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PTEN—hematologic cancer	1.28e-05	0.000159	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CDKN1A—hematologic cancer	1.27e-05	0.000158	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PTEN—hematologic cancer	1.27e-05	0.000158	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NCOR2—hematologic cancer	1.26e-05	0.000157	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAPK8—hematologic cancer	1.25e-05	0.000156	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—AKT1—hematologic cancer	1.25e-05	0.000155	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAPK8—hematologic cancer	1.24e-05	0.000155	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—AKT1—hematologic cancer	1.24e-05	0.000154	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CDA—hematologic cancer	1.22e-05	0.000152	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EP300—hematologic cancer	1.22e-05	0.000152	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EP300—hematologic cancer	1.21e-05	0.000151	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—IDH1—hematologic cancer	1.2e-05	0.00015	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.2e-05	0.00015	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.19e-05	0.000149	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—TXN—hematologic cancer	1.19e-05	0.000148	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ABCC3—hematologic cancer	1.19e-05	0.000148	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTO1—hematologic cancer	1.19e-05	0.000148	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SRC—hematologic cancer	1.19e-05	0.000148	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PC—hematologic cancer	1.18e-05	0.000147	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SRC—hematologic cancer	1.18e-05	0.000147	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SPHK1—hematologic cancer	1.16e-05	0.000145	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—VEGFA—hematologic cancer	1.15e-05	0.000144	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—VEGFA—hematologic cancer	1.15e-05	0.000143	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—STAT3—hematologic cancer	1.14e-05	0.000142	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NRAS—hematologic cancer	1.14e-05	0.000142	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.14e-05	0.000142	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GBA—hematologic cancer	1.14e-05	0.000142	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—STAT3—hematologic cancer	1.13e-05	0.000141	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NRAS—hematologic cancer	1.13e-05	0.000141	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—UGT1A1—hematologic cancer	1.12e-05	0.000139	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.1e-05	0.000137	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAPK3—hematologic cancer	1.09e-05	0.000136	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC22A1—hematologic cancer	1.09e-05	0.000136	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CRABP1—hematologic cancer	1.09e-05	0.000136	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAPK3—hematologic cancer	1.08e-05	0.000135	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MYC—hematologic cancer	1.06e-05	0.000132	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALOX5—hematologic cancer	1.06e-05	0.000132	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.06e-05	0.000132	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TGFB1—hematologic cancer	1.06e-05	0.000132	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MYC—hematologic cancer	1.05e-05	0.000131	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TGFB1—hematologic cancer	1.05e-05	0.000131	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MTAP—hematologic cancer	1.04e-05	0.00013	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NUP98—hematologic cancer	1.03e-05	0.000128	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ADCY7—hematologic cancer	9.98e-06	0.000124	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NCOA3—hematologic cancer	9.98e-06	0.000124	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NUP214—hematologic cancer	9.91e-06	0.000123	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—KRAS—hematologic cancer	9.81e-06	0.000122	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—KRAS—hematologic cancer	9.74e-06	0.000121	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MTR—hematologic cancer	9.7e-06	0.000121	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ABCG2—hematologic cancer	9.7e-06	0.000121	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ENO2—hematologic cancer	9.52e-06	0.000118	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—FHL2—hematologic cancer	9.28e-06	0.000116	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTT1—hematologic cancer	9.23e-06	0.000115	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AGRN—hematologic cancer	9.1e-06	0.000113	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SDC1—hematologic cancer	9.02e-06	0.000112	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CA—hematologic cancer	9.02e-06	0.000112	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	8.96e-06	0.000112	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CA—hematologic cancer	8.95e-06	0.000111	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TP53—hematologic cancer	8.72e-06	0.000109	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TP53—hematologic cancer	8.66e-06	0.000108	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.64e-06	0.000108	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—IDH2—hematologic cancer	8.63e-06	0.000107	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HMMR—hematologic cancer	8.63e-06	0.000107	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HRAS—hematologic cancer	8.34e-06	0.000104	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HRAS—hematologic cancer	8.28e-06	0.000103	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ARNTL—hematologic cancer	8.11e-06	0.000101	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	8.09e-06	0.000101	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6—hematologic cancer	7.98e-06	9.94e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6—hematologic cancer	7.93e-06	9.87e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ACP5—hematologic cancer	7.89e-06	9.82e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CA9—hematologic cancer	7.89e-06	9.82e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NCOR2—hematologic cancer	7.79e-06	9.69e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NQO1—hematologic cancer	7.67e-06	9.55e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CD44—hematologic cancer	7.67e-06	9.55e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—IDH1—hematologic cancer	7.42e-06	9.24e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AKT1—hematologic cancer	7.37e-06	9.17e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTO1—hematologic cancer	7.33e-06	9.13e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—TXN—hematologic cancer	7.33e-06	9.13e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCC3—hematologic cancer	7.33e-06	9.13e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AKT1—hematologic cancer	7.31e-06	9.1e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYCS—hematologic cancer	7.26e-06	9.04e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HSP90AA1—hematologic cancer	7.21e-06	8.98e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SPHK1—hematologic cancer	7.18e-06	8.94e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—UGT1A1—hematologic cancer	6.9e-06	8.59e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC22A1—hematologic cancer	6.71e-06	8.35e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CRABP1—hematologic cancer	6.71e-06	8.35e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALOX5—hematologic cancer	6.54e-06	8.14e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTP1—hematologic cancer	6.4e-06	7.97e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NUP98—hematologic cancer	6.33e-06	7.88e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ADCY7—hematologic cancer	6.15e-06	7.65e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NCOA3—hematologic cancer	6.15e-06	7.65e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NUP214—hematologic cancer	6.1e-06	7.6e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCG2—hematologic cancer	5.98e-06	7.44e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MTR—hematologic cancer	5.98e-06	7.44e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTM1—hematologic cancer	5.88e-06	7.32e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NCOR1—hematologic cancer	5.88e-06	7.32e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ENO2—hematologic cancer	5.86e-06	7.3e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTT1—hematologic cancer	5.69e-06	7.08e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SDC1—hematologic cancer	5.56e-06	6.92e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MTHFR—hematologic cancer	5.2e-06	6.47e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CD44—hematologic cancer	4.73e-06	5.88e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NQO1—hematologic cancer	4.73e-06	5.88e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYCS—hematologic cancer	4.47e-06	5.57e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	4.44e-06	5.53e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CG—hematologic cancer	4.37e-06	5.44e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CREBBP—hematologic cancer	4.05e-06	5.04e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.94e-06	4.91e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CD—hematologic cancer	3.84e-06	4.78e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALB—hematologic cancer	3.79e-06	4.72e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.73e-06	4.65e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3R1—hematologic cancer	3.62e-06	4.51e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.62e-06	4.51e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.62e-06	4.51e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CB—hematologic cancer	3.35e-06	4.17e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.2e-06	3.99e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTEN—hematologic cancer	2.89e-06	3.6e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—EP300—hematologic cancer	2.76e-06	3.43e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.69e-06	3.35e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.49e-06	3.1e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.36e-06	2.94e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALB—hematologic cancer	2.33e-06	2.91e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.23e-06	2.78e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.06e-06	2.57e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CA—hematologic cancer	2.04e-06	2.54e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTEN—hematologic cancer	1.78e-06	2.22e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—EP300—hematologic cancer	1.7e-06	2.11e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AKT1—hematologic cancer	1.67e-06	2.07e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.26e-06	1.56e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AKT1—hematologic cancer	1.03e-06	1.28e-05	CbGpPWpGaD
